Edition:
India

Amneal Receives Abbreviated New Drug Application Approval For Eluryng, The First Generic Nuvaring


Thursday, 12 Dec 2019 

Dec 12 (Reuters) - Amneal Pharmaceuticals Inc ::AMNEAL RECEIVES ABBREVIATED NEW DRUG APPLICATION APPROVAL FOR ELURYNG™, THE FIRST GENERIC NUVARING®.AMNEAL PHARMACEUTICALS INC - HAS INITIATED COMMERCIALIZATION ACTIVITIES FOR ELURYNG.AMNEAL PHARMACEUTICALS - ANNOUNCES FDA APPROVAL OF ELURYNG, ONE OF 15 NEW PRODUCTS CO EXPECTS TO LAUNCH OVER NEXT 18 TO 24 MONTHS.